Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global amyotrophic lateral sclerosis treatment market size reached US$ 719.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 969.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.

Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene mutation, disorganized immune response, chemical imbalance, etc. Some of the common symptoms of ALS include muscle stiffness, twitching of the muscles, weakness in the legs or arms, cognitive and behavioral changes, trouble in swallowing, slurred speech, etc. The diagnosis of ALS relies on medical history, physical examination, electrodiagnostic testing, and neuroimaging.

Amyotrophic Lateral Sclerosis Treatment Market Trends:
The rising incidences of neurodegenerative disorders due to changing lifestyle patterns and hectic schedules of the individuals are primarily driving the Amyotrophic Lateral Sclerosis Treatment treatment market. Besides this, the expanding geriatric population, who are more susceptible to such neurological ailments, is also augmenting the market growth. Furthermore, several NGOs and private organizations are undertaking numerous initiatives to increase awareness regarding the diagnosis and treatment of ALS among the masses. This, in turn, is creating a positive outlook for the market. Additionally, the growing penetration of targeted and symptomatic treatment options for ALS is acting as a significant growth-inducing factor. Moreover, the elevating focus on clinical trials and faster approval of oral drugs for ALS treatment is also bolstering the market growth. Moreover, the increasing strategic collaborations among various research institutes to develop innovative treatment procedures that aim at enhancing muscle function, immune modulation, and neuroprotection are further catalyzing the global market. In the coming years, the continuous upgradation of healthcare infrastructures along with elevating penetration of refurbishment policies will continue to drive the global amyotrophic lateral sclerosis (ALS) treatment market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global amyotrophic lateral sclerosis treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on ALS type, drug type, diagnosis type, treatment and distribution channel.

Breakup by ALS Type:

Sporadic ALS
Familial ALS

Breakup by Drug Type:

Marketed Drugs
Emerging Drugs

Breakup by Diagnosis Type:

Electromyogram
MRI
Blood and Urine Tests
Spinal Tap
Muscle Biopsy

Breakup by Treatment:

Medication
Stem Cell Therapy
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V.

Key Questions Answered in This Report:
How has the global amyotrophic lateral sclerosis treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global amyotrophic lateral sclerosis treatment market?
What are the key regional markets?
What is the breakup of the market based on the ALS type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the diagnosis type?
What is the breakup of the market based on the treatment?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global amyotrophic lateral sclerosis treatment market and who are the key players?
What is the degree of competition in the industry?